Genetic variations in MicroRNA genes and cancer risk: A field synopsis and meta‐analysis

Cancer risk has been associated with certain gene variations in microRNA (miRNA), but conflicting evidence warrants re‐assessing of significant results in meta‐analyses. We summarized published meta‐analyses that assess the associations between miRNA polymorphism and cancers to show the validity of the findings.

[1]  T. Yasui,et al.  The Association Between Three Genetic Variants in MicroRNAs (Rs11614913, Rs2910164, Rs3746444) and Prostate Cancer Risk , 2018, Cellular Physiology and Biochemistry.

[2]  Baosen Zhou,et al.  Association between miR-146a rs2910164 polymorphism and specific cancer susceptibility: an updated meta-analysis , 2017, Familial Cancer.

[3]  Baosen Zhou,et al.  A Meta-Analysis of miR-499 rs3746444 Polymorphism for Cancer Risk of Different Systems: Evidence From 65 Case-Control Studies , 2018, Front. Physiol..

[4]  Qian Xu,et al.  A comprehensive evaluation for polymorphisms in let-7 family in cancer risk and prognosis: a system review and meta-analysis , 2018, Bioscience reports.

[5]  Fan Wang,et al.  Association Between miR-149 Gene rs2292832 Polymorphism and Risk of Gastric Cancer. , 2018, Archives of medical research.

[6]  S. Mocellin,et al.  Genetic susceptibility to bone and soft tissue sarcomas: a field synopsis and meta-analysis , 2018, Oncotarget.

[7]  Shuqun Zhang,et al.  Association of miR-196a2 rs11614913 and miR-499 rs3746444 polymorphisms with cancer risk: a meta-analysis , 2017, OncoTarget.

[8]  M. Eisenhut,et al.  Statistical controversies in clinical research: overlap and errors in the meta-analyses of microRNA genetic association studies in cancers , 2017, Annals of oncology : official journal of the European Society for Medical Oncology.

[9]  Yonglan Zheng,et al.  The association between miR-423 rs6505162 polymorphism and cancer susceptibility: a systematic review and meta-analysis , 2017, Oncotarget.

[10]  Xixi Zhao,et al.  Association between three functional microRNA polymorphisms (miR-499 rs3746444, miR-196a rs11614913 and miR-146a rs2910164) and breast cancer risk: a meta-analysis , 2016, Oncotarget.

[11]  S. Nie,et al.  Association between microRNA-27a rs895819 polymorphism and risk of colorectal cancer: A meta-analysis. , 2016, Cancer genetics.

[12]  John P A Ioannidis,et al.  The Mass Production of Redundant, Misleading, and Conflicted Systematic Reviews and Meta-analyses. , 2016, The Milbank quarterly.

[13]  Chen Zf,et al.  Common polymorphisms of the microRNA genes (miR-146a and miR-196a-2) and gastric cancer risk: an updated meta-analysis. , 2015 .

[14]  Hao Liu,et al.  Polymorphisms in four microRNAs and risk of oral squamous cell cancer: a meta-analysis , 2015, Oncotarget.

[15]  S. Lawler,et al.  MicroRNAs in cancer: biomarkers, functions and therapy. , 2014, Trends in molecular medicine.

[16]  Chi-Hung Lin,et al.  MicroRNA-146a directs the symmetric division of Snail-dominant colorectal cancer stem cells , 2014, Nature Cell Biology.

[17]  Haoyan Chen,et al.  MicroRNA sequence polymorphisms and the risk of different types of cancer , 2014, Scientific Reports.

[18]  D. Wan,et al.  Effects of common polymorphisms rs2910164 in miR-146a and rs11614913 in miR-196a2 on susceptibility to colorectal cancer: a systematic review meta-analysis , 2014, Clinical and Translational Oncology.

[19]  Taotao Ma,et al.  MiR-27a modulates the MDR1/P-glycoprotein expression by inhibiting FZD7/β-catenin pathway in hepatocellular carcinoma cells. , 2013, Cellular signalling.

[20]  Zhongwei Cao,et al.  MicroRNA-146a acts as a metastasis suppressor in gastric cancer by targeting WASF2. , 2013, Cancer letters.

[21]  J. Ioannidis,et al.  The Geometric Increase in Meta-Analyses from China in the Genomic Era , 2013, PloS one.

[22]  K. Pan,et al.  Genetic Polymorphisms of miR-146a and miR-27a, H. pylori Infection, and Risk of Gastric Lesions in a Chinese Population , 2013, PloS one.

[23]  Baosen Zhou,et al.  Effects of common polymorphisms rs2910164 in miR-146a and rs3746444 in miR-499 on cancer susceptibility: a meta-analysis , 2013, Molecular Biology Reports.

[24]  F. Slack,et al.  MicroRNAs en route to the clinic: progress in validating and targeting microRNAs for cancer therapy , 2011, Nature Reviews Cancer.

[25]  H. Eguchi,et al.  miR-146a suppresses the sensitivity to interferon-α in hepatocellular carcinoma cells. , 2011, Biochemical and biophysical research communications.

[26]  Yong Li,et al.  MicroRNAs in NF-kappaB signaling. , 2011, Journal of molecular cell biology.

[27]  D. Heo,et al.  MicroRNA-146a Downregulates NFκB Activity via Targeting TRAF6 and Functions as a Tumor Suppressor Having Strong Prognostic Implications in NK/T Cell Lymphoma , 2011, Clinical Cancer Research.

[28]  David Baltimore,et al.  Function of miR-146a in Controlling Treg Cell-Mediated Regulation of Th1 Responses , 2010, Cell.

[29]  C. Harris,et al.  Genetic variation in microRNA networks: the implications for cancer research , 2010, Nature Reviews Cancer.

[30]  M. Kay,et al.  How do miRNAs mediate translational repression? , 2010, Silence.

[31]  Zhiwei Wang,et al.  miR-146a suppresses invasion of pancreatic cancer cells. , 2010, Cancer research.

[32]  Kedar S Vaidya,et al.  Breast cancer metastasis suppressor 1 up-regulates miR-146, which suppresses breast cancer metastasis. , 2009, Cancer research.

[33]  S. Schokrpur,et al.  Expression of microRNA-146 suppresses NF-κB activity with reduction of metastatic potential in breast cancer cells , 2008, Oncogene.

[34]  Barbara Jarzab,et al.  Common SNP in pre-miR-146a decreases mature miR expression and predisposes to papillary thyroid carcinoma , 2008, Proceedings of the National Academy of Sciences.

[35]  Donald C. Chang,et al.  Loss of mir-146a function in hormone-refractory prostate cancer. , 2008, RNA.

[36]  C. Croce,et al.  MicroRNA signatures in human cancers , 2006, Nature Reviews Cancer.

[37]  D. Baltimore,et al.  NF-κB-dependent induction of microRNA miR-146, an inhibitor targeted to signaling proteins of innate immune responses , 2006, Proceedings of the National Academy of Sciences.

[38]  D. Clayton,et al.  Betting odds and genetic associations. , 2004, Journal of the National Cancer Institute.

[39]  Nathaniel Rothman,et al.  Assessing the Probability That a Positive Report is False: An Approach for Molecular Epidemiology Studies , 2004 .

[40]  W. Thompson,et al.  The genetic attributable risk of breast and ovarian cancer , 1996, Cancer.

[41]  H. Xue,et al.  Common polymorphisms of the microRNA genes (miR-146a and miR-196a-2) and gastric cancer risk: an updated meta-analysis. , 2015, Genetics and molecular research : GMR.

[42]  Yan Sun,et al.  microRNA-27a functions as a tumor suppressor in esophageal squamous cell carcinoma by targeting KRAS. , 2014, Oncology reports.

[43]  Yingjun Li,et al.  A genetic variant in MiR-146a modifies digestive system cancer risk: a meta-analysis. , 2014, Asian Pacific journal of cancer prevention : APJCP.

[44]  J. Weidhaas,et al.  SNPing cancer in the bud: microRNA and microRNA-target site polymorphisms as diagnostic and prognostic biomarkers in cancer. , 2013, Pharmacology & therapeutics.

[45]  G. Sun,et al.  Quantitative assessment of the association between miR-196a2 rs11614913 polymorphism and gastrointestinal cancer risk , 2012, Molecular Biology Reports.

[46]  友國 晃.  miR-146a suppresses the sensitivity to interferon-α in hepatocellular carcinoma cells , 2012 .